Acrylamide-reducing yeast technology being commercialised


Monday, 10 December, 2018

Acrylamide-reducing yeast technology being commercialised

Renaissance BioScience’s non-GMO acrylamide-reducing yeast enzyme Acryleast will be available to food and beverage manufacturers from Kerry Taste & Nutrition Europe from next year.

Acryleast is suitable for use in a range food and beverage products, including biscuits, crackers, French fries, potato crisps, coffee, infant food and more, where it is claimed the enzyme will reduce acrylamide by up to 90%. This clean-label, effective and versatile solution has no or minimal changes to manufacturing processes and no impact on flavour, aroma and texture.

This licence agreement is quite timely given new EU acrylamide regulations, which came into effect in April 2018, and California’s Proposition 65, which requires “potentially harmful” warning labels relating to acrylamide (on food and beverage packaging or in food outlets).

Kerry is adding the enzyme to its clean-label product range.

Related News

Tate & Lyle expands next-gen sweetener program with BioHarvest Sciences

The expanded program aims to develop plant-based sweetening solutions tailored to the evolving...

Debut and Oterra partner to develop alternative to Red 40

Oterra is teaming up with the AI-powered biotechnology business to create and scale a natural...

Seprify and BIOGRUND develop titanium dioxide-free tablet coating for nutraceuticals

BIOGRUND partners with Seprify to bring a clean-label nutraceutical tablet coating to market.


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd